greater understanding of the aetiology of renal disease in the general population.
been suggested that heterozygotes are at increased risk Introduction of obesity and hypertension.
Methods. We describe renal disease in relatives of 109
Bardet-Biedl syndrome (BBS) (MIM 209900) is an UK BBS patients. Using PCR with fluorescent microsautosomal recessive condition with a wide spectrum of atellite markers we amplified DNA derived from renal clinical features. The cardinal manifestations in homotumours of affected parents to determine whether there zygous (affected ) individuals comprise, rod/cone dyswas loss of heterozygosity at any of four BBS loci and trophy, obesity, polydactyly, hypogonadism, learning two other gene loci associated with clear cell renal cell difficulties and renal defects [1, 2] . Minor features carcinoma (CC-RCC ).
include diabetes mellitus, hepatic fibrosis, speech defiResults. CC-RCC was diagnosed in three of 180 BBS cit, dental anomalies and altered behaviour. A diaparents and there was loss of heterozygosity at BBS1 gnosis is made by the presence of four major criteria (11q13) in the tumour tissue of one of these subjects. [3] . In addition, there was a high incidence of renal agenesis Renal abnormalities have been described in up to in siblings of BBS patients and two BBS families were 100% of BBS patients [2] , and renal failure is the identified with apparently dominant inheritance of major cause of morbidity and early mortality in BBS renal malformations. In one family we were able to [2] . Dysplasia, chronic glomerulonephritis, cystic tubudemonstrate that renal malformations segregated with lar disease, calyceal and lower urinary tract malformathe BBS2 locus (16q21).
tions, and defects of tubular concentrating ability have Conclusions. Since all parents and two-thirds of siball been reported [4] . lings of BBS patients must be heterozygous for BBS BBS is a genetically heterogeneous disease with loci mutations, our observations may implicate BBS genes thus far identified on 11q13 (BBS1), 16q21 (BBS2), in the pathogenesis of both renal cancer and malforma3p13 (BBS3), and 15q23 (BBS4), each associated with tions, both disorders of precursor cell growth and a similar phenotype in studies to date [5] [6] [7] [8] . Very differentiation. We suggest these observations may recently, a fifth locus has been mapped to 2q31 (BBS5) have important implications for screening potential in a single Newfoundland family [9] . BBS carriers for kidney disease and may lead to a
In several recessive conditions, partial disease manifestations in heterozygote carriers have been observed. Carriers of ataxia telangiectasia have an increased risk Correspondence and offprint requests to: Dr P. L. Beales, Molecular of developing breast cancer [10] , and carriers of Medicine Unit, Institute of Child Health, University College London, autosomal recessive-type Alport's syndrome may have suggested in BBS families with an increased incidence precipitate out the DNA. This was then washed in 70% of obesity, hypertension and diabetes [12, 13] . We ethanol and resuspended in TE ready for use in the PCR.
completed a clinical survey of 109 BBS patients and Second, we sought linkage of renal malformation phenotheir relatives living in the UK [14] , and observed a type to the four BBS loci that were recognised at the time high prevalence of clear cell renal cell carcinoma of study. For this, DNA was extracted from peripheral blood (CC-RCC ) and renal malformations amongst the leucocytes and genotyped as previously described [15] . unaffected relatives. We now describe several cases and two pedigrees of renal malformations and present the results of a search for allele loss at BBS loci in three Primers obligate carrier parents who developed CC-RCC. We suggest that individuals heterozygous for BBS muta-Genethon map derived primer sequences were used as tions are at increased risk of these disorders. Our described by Beales et al. [15] . The primers were commercially synthesized (Life Technologies Inc.) and one primer of observations have implications for understanding the each pair was labelled in the 5∞ position with a phosphoramidpathogenesis of disorders of kidney growth and differite dye (FAM, HEX or TET-Applied Biosystems). Finally entiation, and have potentially important practical each primer was purified using HPLC.
implications for the screening of BBS relatives.
Materials and methods

Polymerase chain reaction and gel electrophoresis
Each target DNA sequence was amplified by the polymerase Subjects chain reaction (PCR) incorporating the fluorescently labelled microsatellite markers flanking known loci. Forty nanograms BBS individuals and their first-degree relatives were interof genomic DNA or a 1-ml aliquot of tumour-derived DNA viewed by questionnaire through the Guy's Hospital Bardet-(diluted 1520) was amplified in 10 ml reaction volumes conBiedl database and the Laurence-Moon-Bardet-Biedl Society taining 1 ml PCR buffer (×10) (670 mM Tris-HCl pH 8.0, members' list, and have been reported in a separate manu-166 mM NH 4 SO 4 , 67 mM MgCl 2 , 1.7 mg/ml BSA), 5 mM script [14] ; this study constitutes the largest single survey of of each dNTP (dATP, dCTP, dGTP, dTTP), 2 pmol of each living BBS patients. The questionnaire addressed prior knowfluorescent primer (LTI ) and 0.6 U of Taq polymerase ledge of significant family medical history. Medical notes (Promega Corporation). The PCR was carried out in a were sought, with patients' consent, for verification of dia-PTC-100 thermal cycler (Genetic Research Instrumentation gnosis, treatment and renal disease. In the cases of reported Ltd ). Typical reaction conditions were as follows, initial renal malformations, radiological reports, ultrasound scans denaturation at 94°C for 10 min then 24 cycles of 94°C for and intravenous pyelograms were obtained; however, no 45 s, annealing temperatures 54-60°C for 45 s, extension at systematic renal ultrasound imaging was performed on the 72°C for 2 min followed by a final extension of 72°C for relatives of the BBS probands. One hundred and twenty-five 10 min. The cycle number was optimised for each tissueprobands from 105 families were sent questionnaires with an derived DNA sample to generate comparable product peaks explanatory letter inviting participation, and 111 returned in the determination of allele loss. them completed. Only two patients did not fulfil inclusion criteria. Where appropriate, patients and relatives were seen in the clinic, at home, or were contacted by telephone to obtain further details. All histological analyses were per-Polyacrylamide gel electrophoresis formed by renal pathologists.
A sample (1 ml ) of PCR product was combined with 2 ml of de-ionized formamide and 0.5 ml of a fluorescent size marker
DNA extraction
(GS500-Tamra, Applied Biosystems). After 3 min denaturation at 94°C, the sample was loaded onto a 6% polyacrylWe used two molecular strategies to investigate selected amide denaturing gel (Sequagel-6, National Diagnostics) in kindreds and individuals. First, we sought evidence for loss 1×TBE buffer. The gel was run on an automated DNA of heterozygosity in three tumour samples at BBS1-4 (the fluorescent fragment analyser (Model 373A, Applied loci known to be associated with BBS at the time of this Biosystems) for 5 h at 35 W and 40°C. Alleles sizes, relative study), the Von Hippel Lindau (VHL) and 3p14 region (both heights and areas of the peaks were assigned using the regions associated with familial RCC ). DNA was extracted GENESCAN and GENOTYPER software (ABI ). from formalin-fixed, paraffin-embedded blocks of normal kidney and renal tumour. After micro-dissection of 20-mm sections, DNA was recovered from tumour and normal renal tissue, using a phenol-chloroform extraction method. Briefly, Allele ratios and determination of LOH the sample was de-waxed in xylene for 30 min and then rehydrated by sequential washes in 100, 80, 50% ethanol and The peak height of the two highest alleles (if heterozygous) in the paired normal and tumour samples were determined. finally in distilled water. The sample then underwent digestion by resuspension in lysis buffer (150 mM NaCl, 25 mM In the case of a single (homozygous) peak, the area was determined for the paired samples. The ratio of alleles was EDTA, pH 8.0) with proteinase K (10 mg/ml ) and 10% SDS. The mix is incubated at 55°C for 72 h. Purification was calculated for each normal and tumour sample as described by Cawkwell et al. [16 ] . The results are expressed in the achieved, first by adding phenol, chloroform, isoamylalcohol (2552451) to the tube and then centrifuging to a pellet. The range 0.00-1.00, where a ratio of 0.50 or less indicates significant allelic loss. The PCR was repeated a second time supernatant was then removed and added to an equal volume of chloroform, isoamylalcohol (2451). Following a further to exclude artefacts.
VHL mutation detection
CC-RCC. One parent (parent 2) was found to have a heterozygous missense mutation in the VHL gene Germline VHL gene mutations were sought as described (C470G, Pro86Arg) although, there was no antecedent previously [17] . In brief, Southern analysis was first per-medical or family history to suggest such a diagnosis, formed on blood DNA to detect gene deletions, and single as is recognized in this condition. However, even if strand conformation polymorphism (SSCP) analysis was this parent is removed from the analysis, there remains performed to detect intragenic mutations. Direct sequencing a significantly increased risk of CC-RCC. When this of the whole coding region was performed to characterise a proportion of 1.11% (2/180) with RCC is compared mutation in patients with a SSCP band shift and to exclude with the general population cumulative risk of developa mutation in those with normal SSCP analysis. These ing RCC under 55 years (1/1041), the relative risk investigations are expected to identify mutations in at least 80% of germline VHL gene mutations [17] .
becomes 11-fold (P=0.017, binomial exact test (twosided )).
Using PCR (repeated once), we amplified tumour Statistics DNA with microsatellite markers from BBS1-4 and Ninety-five per cent confidence intervals (C.I.) were calcu-from 3p. Significant allelic loss was present in two BBS lated for the relative risk of developing CC-RCC. To compare parents (2 and 3) with CC-RCC ( Fig. 2) . Parent 2 proportions, we used the binomial exact test or x 2 test. P-showed LOH at D11S480 (BBS1) with an allelic ratio values <0.05 were taken to be significant. of 0.33 and at D3S1300 (3p14) with a ratio of 0.50. Parent 3 was found to have significant LOH at D3S1263 (VHL) with a ratio of 0.27 (but no germline Results mutation of VHL found). Parent 1 was not found to have significant LOH at BBS1-4 and the VHL loci.
Cancers
In addition, we also typed parents 2 and 3 using 38 random STRPs evenly spaced across the genome (on Three of 180 parents, all Caucasians, aged 37 years (parent 1, male), 52 years (parent 2, male) and a average one per chromosome arm) ( Table 1 ) and no significant LOH was documented. 40-year-old female (parent 3) had renal adenocarcinoma, all with clear cell histology. Parent 1 was asymptomatic, and was diagnosed by ultrasound scan when Malformations asked to take part in a research programme involving his daughter, who has BBS and chronic renal failure. Of the 109 BBS subjects, five of 123 unaffected siblings (4.1%) had one or more congenital renal malformaThis parent also had evidence of malformation, with a duplex kidney and ureter. His carcinoma was com-tions. Two (1.6%) had unilateral renal agenesis, of whom one had a complex malformation of the solitary pletely resected and he remains disease-free 3 years after nephrectomy ( Fig. 1) . At diagnosis, parent 2 was urinary tract comprising a duplication and a ureterocoele ( Table 2 ). According to Kiprov et al. in a survey symptomatic, with metastatic disease, and died soon after. The carcinoma in parent 3 was diagnosed during of 9200 autopsies the incidence of unilateral renal agenesis in the general population is about one in 1000 a radiological assessment for potential kidney donation to her BBS daughter, who had end-stage renal failure. [20] . Therefore, the occurrence of unilateral absence of functioning renal tissue in 2/123 BBS siblings represThis parent is alive and well 3 years after nephrectomy. None of these parents were known to have the follow-ents a 20-fold increase (P=0.007). In addition, three (2.4%) had vesicoureteric reflux and three (2.4%) had ing recognized risk factors for renal carcinoma as reviewed by Vogelzang and Stadler [18] : chronic dia-duplication of the ureter and pelvis. However, these incidences may fall into those recognized for the genlysis, obesity, cigarette smoking, arterial hypertension, oestrogen therapy, and occupational exposure to heavy eral population [21, 22] . In addition, it is interesting to note that of these five siblings, one grandparent had metals and petroleum products.
The proportion of parents with renal tumours was unilateral renal agenesis, with a solitary kidney in endstage renal failure, and another parent (parent 1, 1.67% (3/180). The general population risk of CC-RCC rises sharply after 55 years [19] , while the above) had a duplex renal tract. These reports of renal malformation were all incidental, and neither the parcumulative risk of developing CC-RCC under 55 years of age in the general population is 1 in 1041 [19] . ents nor the siblings had been screened with a view to observing renal abnormalities. In addition, we recorded These three parents, who were relatively young at the time of diagnosis of CC-RCC, therefore, have a signi-a prominent history of renal malformations in two kindreds, now described in detail. ficantly increased risk of CC-RCC (P=0.0007, bi-nomial exact test (two-sided)). Extrapolating from this, the relative cumulative risk of parents of BBS Family A children developing CC-RCC under 55 years is 17 times (95% CI=3.6-49.9) that of the general The proband initially characterised by Runge et al. [23] , was a 4-year-old BBS boy who died from renal population.
It was important to determine whether any of these failure secondary to renal dysplasia. His father (parent 2) died from CC-RCC, but was not known to have parents were carrying a germline mutation in the VHL gene, which might contribute to the development of had any renal malformation and there is no history of renal malformation in his family. The proband's loci [15] . To determine the carrier status of the unaffected sister, she and her family were also genomother is healthy, but has a strong family history of renal malformations, which appear to be inherited in typed ( Fig. 4) . She, her son and another daughter have inherited the same chromosome segment, which is of an autosomal dominant manner with variable expression ( Fig. 3) . These malformations comprise combina-grand-paternal origin, as that shared by the affected twins. It would appear that they all carry the BBS2 tions of renal agenesis and contralateral renal dysplasia or renal tract duplications. The mother herself has gene-containing region. However, the daughter has a normal kidney structure on intravenous pyelography. normal renal architecture and function (assessed by ultrasound scan and plasma creatinine). It is unfortunate that DNA samples or post-mortem material was not available from any member of the maternal kindred as our hypothesis could be further supported by shar-Discussion ing of one or more BBS alleles between the mother and her relatives with renal malformations.
Clear cell renal cell carcinoma
Renal carcinomas account for 2% of all cancers and Family B for 80-85% of malignant kidney tumours [25] . Known risk factors for CC-RCC include chronic dialysis, This family (Fig. 4 ) comprises dizygotic twins with BBS. Their unaffected sister complained of left loin obesity, cigarette smoking, arterial hypertension, oestrogen therapy, and occupational exposure to heavy pain as a teenager, and was found to have hypertension. On investigation, a small dysplastic left kidney metals and petroleum products [18] . Heritable factors are increasingly recognized as being critical to the was found and later removed, and her hypertension resolved. She also had vesicoureteric reflux into her pathogenesis of many tumours, and the risk of developing CC-RCC increases on average 1.6-fold where there right kidney, with recurrent pyelonephritis. Her youngest son (now 2 years of age) had critical aortic stenosis is an affected first-degree relative [18] .
The most common form of familial clear cell RCC requiring valvotomy on day 5. Antenatally, he was noted to have a multicystic dysplastic left kidney, is VHL disease, but a non-VHL clear cell variant is also recognized [26 ] . Recent studies of nine kindreds which was non-functional (confirmed postnatally by radioisotope scan) and a micturating cystogram with familial non-VHL clear cell RCC ( HCRC ) have demonstrated that most patients develop RCC <50 revealed vesico-ureteric reflux in the contralateral system. Six months later, the multicystic kidney had years of age ( EM, unpublished observations). The molecular basis of HCRC is unknown but the disease involuted as has been reported in other individuals [24] . Haplotype analysis of this family found it to be is not allelic with VHL disease or familial papillary renal cell carcinoma [26; EM, unpublished observaconsistent with linkage to BBS2 (16q21), which is further supported by exclusion from the other three tions] and it is possible that BBS loci might be implic- Table 1 . Microsatellite markers used in study . 3 . Family A. This pedigree illustrates dominant inheritance of D4S405 (p) two renal malformations; duplication of the kidney and renal tract D4S415 (q) D15S114 u and unilateral/bilateral renal agenesis in the proband's maternal D15S204 N BBS4 family. There was no family history of renal malformations on the D5S419 (p) D15S984 w paternal side. However, the proband's father has been found to D5S410 (q) carry a germline VHL mutation.
of CC-RCC in these parents (37, 40 and 52 years) is D16S514 w striking (CC-RCC generally predominates in the
7th-8th decades of life [25] ), and suggests a genetic
aetiology. As the carrier rate for BBS in the UK is
approximately 1 in 160, we would expect there to be
around 350 000 BBS gene carriers ( UK population D18S61 (q)~5 6 million). Based on these figures, 1 in 90 of the D9S171 (p) carriers may be at risk of developing CC-RCC (3889
in total ). The proportion of early onset RCC which D10S189 (p) could be accounted for by BBS heterozygotes may be
as high as 6.9%.
D21S268 (q)
Secondly, is there molecular evidence to implicate
BBS loci in the pathogenesis of these cancers? Since
BBS is a recessive syndrome, each parent is heterozygous for a BBS mutation. Many cancer susceptibility p=short arm, q=long arm. Markers with * denote loss of hetero-disorders result from tumour suppressor gene inactivazygosity in renal tumours of BBS parents. tion and loss of the wild-type allele (detected by LOH analysis) is frequent in the tumour. Our demonstration (20) at 3p14 (D3S1300), a region previously implicated in Duplication of ureter and pelvis 3 (2.4%) 5% (21) CC-RCC development but not at 3p25 (D3S1263 close Vesicoureteric reflux 3 (2.4%) 1-2% (22) to VHL). BBS3 maps to 3p13. Germline mutations in the VHL gene are associated with a high risk of earlyonset and multicentric CC-RCC and somatic VHL ated in HCRC or represent a low penetrance clear cell RCC susceptibility allele.
gene mutations or methylation are found in up to 70% of CC-RCC cell lines and primary tumours [27] . In respect of the novel observations made in this study, there are two key questions to consider. First, However, VHL gene inactivation is not sufficient to initiate CC-RCC and LOH at 3p12-p21 is frequent in is the occurrence of renal adenocarcinoma higher than would be expected by chance? Our observation of three CC-RCC with and without VHL gene inactivation [27] . The 3p12-p21 interval contains several candidate cases of CC-RCC in 180 parents was statistically significant (P=0.0007) when compared with the age-CC-RCC TSG regions: 3p12 and 3p21.3 which are homozygously deleted in breast and lung cancer cell related, cumulative general population risk. Even if we are to remove parent 2 on the basis that his predisposi-lines and 3p14 which contains the FRA3B fragile site [28] and the FHIT gene [29] . It is of interest that tion to RCC was due entirely to carriage of a VHL mutation and that there is no BBS contribution, D3S1300 (3p14) was deleted in the parent 2 tumour, but it is not possible to know the relevance of this the observations remain statistically significant. Furthermore, the relatively young age of development CC-RCC development in this case. In addition, there was possibly LOH at BBS4 in the same tumour, but developing CC-RCC in both heterozygotes and homozygotes would depend on the frequency of allelic loss the allelic ratio of 0.65 did not attain the conventional level of significance. Although concomitant regions of at the second locus (interactor). The finding of a missense VHL mutation in parent 2 as well as LOH LOH are well described in many tumours [30, 31] , the significance of, and interplay between, the different at a VHL-associated marker in parent 3 is entirely consistent with this hypothesis. Now that a fifth BBS loci are unknown.
We conclude that LOH at BBS loci in CC-RCC in gene (2q31) has been mapped [9], it will also be interesting to examine this locus in these tumours. BBS heterozygotes is unlikely to have arisen by chance, as random chromosome-wide analysis did not reveal widespread LOH (Table 1) . If BBS genes function as Renal malformations tumour-suppressors, then BBS homozygotes must also be at increased risk of CC-RCC. We have encountered The term 'kidney malformation' describes diverse anomalies [33] . In renal agenesis the kidney is absent. only one case of CC-RCC in a BBS patient (PLB, personal observation) and only one case is reported in 'Dysplastic kidneys' refer to poorly differentiated organs, which frequently contain cysts ('multicystic the literature [32] .
An alternative hypothesis may be that there are dysplastic kidney'). Malformations affecting the lower urinary tract include duplication, vesicoureteric reflux epistatic interactions between BBS loci (and perhaps other renal developmental genes) such that a loss of a and ureterocoele. It should also be noted that multicystic dysplastic kidneys can involute pre-or postnatally normal allele at more than one locus increases the risk for CC-RCC. If this were so, then the relative risk of [24] , driven by excess apoptosis [33] , to give an appearance of 'agenesis'. Human renal malformations sound scans for occult renal tract malformations, since these may be associated with hypertension or renal may be inherited, either in isolation or as part of syndromes (e.g. renal agenesis and olfactory bulb mal-impairment. Furthermore, renal carcinoma would have to be excluded in all parents of BBS patients, since formation in Kallmann syndrome [33] , and vesicoureteric reflux with optic nerve colobomas in the renal-early detection and treatment may improve the prognosis. coloboma syndrome [33] population are unilateral renal agenesis, 1/1000; unilat-Action Research Project Grant (S/P/8178) supports ASW. We are eral multicystic dysplastic kidney, 1/5000; bilateral grateful to the Laurence-Moon-Bardet-Biedl Syndrome Society for agenesis and/or dysplasia, 1/5000-10 000; vesicouret-their help and encouragement and to the patients and relatives who participated in this study. eric reflux, 1/100; unilateral duplex ureter, 1/20 [20] [21] [22] 36 ] . Therefore, the occurrence of unilateral absence of functioning renal tissue in two of 123 BBS References siblings represents a significant 20-fold increase. As no formal radiological or ultrasound screening of the
